FdaApplication
ANDA 217071
Identifiers
- fda_app_no: ANDA217071
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2024-09-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERTUGLIFLOZIN | ERTUGLIFLOZIN | 15MG | TABLET;ORAL |
| ERTUGLIFLOZIN | ERTUGLIFLOZIN | 5MG | TABLET;ORAL |
2 products